Praxis recently provided recruitment services to a pharmaceutical company for a study to test a medication for a women’s health indication. This was the third successful brand extension for their client. In this latest campaign execution, specific social media tactics were included to help drive the 1365% ROI the sponsor realized. This latest recruitment program over-delivered on patients by 73% for two thirds the planned recruitment investment.
According to David Fox, President and CEO of Praxis “As we continue to support and partner with this sponsor each step builds upon the previous. Our initial brand building efforts and up-front planning pay dividends with heightened awareness among our patient population. All of this adds up to saved money and time for the sponsor."
The study was centrally managed and patient recruitment results were available in real-time, 24/7 using PraxisDirect®, Praxis’ online study management technology. PraxisDirect also played a role in the daily life of the study coordinator by offering key assistance and tracking regarding patient outcomes.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.